Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (IHBVRL)

This study is currently recruiting participants.
Verified February 2013 by Fudan University
Sponsor:
Information provided by (Responsible Party):
Junning Cao, Fudan University
ClinicalTrials.gov Identifier:
NCT01210287
First received: September 27, 2010
Last updated: February 28, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)